17 results on '"BOUTROU, Mathilde"'
Search Results
2. Correction to: Human Q Fever on the Guiana Shield and Brazil: Recent Findings and Remaining Questions
- Author
-
Epelboin, Loïc, Eldin, Carole, Thill, Pauline, de Santi, Vincent Pommier, Abboud, Philippe, Walter, Gaëlle, Melzani, Alessia, Letertre-Gibert, Paule, Perez, Lucas, Demar, Magalie, Boutrou, Mathilde, Fernandes, Jorlan, Cermeño, Julman Rosiris, Panizo, Maria Mercedes, Vreden, Stephen G. S., Djossou, Félix, Beillard, Emmanuel, de Waard, Jacobus H., and de Lemos, Elba Regina Sampaio
- Published
- 2023
- Full Text
- View/download PDF
3. Tuberculosis in prison: What about after release? The example of French Guiana
- Author
-
Niaux, Moise, primary, Boutrou, Mathilde, additional, Daniel, Marie, additional, Schiemsky, Vanessa, additional, Vierendeels, Evelyn, additional, Djossou, Félix, additional, Nacher, Mathieu, additional, Huber, Florence, additional, and Bonifay, Timothée, additional
- Published
- 2024
- Full Text
- View/download PDF
4. Human Q Fever on the Guiana Shield and Brazil: Recent Findings and Remaining Questions
- Author
-
Epelboin, Loïc, Eldin, Carole, Thill, Pauline, de Santi, Vincent Pommier, Abboud, Philippe, Walter, Gaëlle, Melzani, Alessia, Letertre-Gibert, Paule, Perez, Lucas, Demar, Magalie, Boutrou, Mathilde, Fernandes, Jorlan, Cermeño, Julman Rosiris, Panizo, Maria Mercedes, Vreden, Stephen GS, Djossou, Félix, Beillard, Emmanuel, de Waard, Jacobus H., and de Lemos, Elba Regina Sampaio
- Published
- 2021
- Full Text
- View/download PDF
5. Case Report: Acute Brucellosis Due to Brucella suis in a Brazilian Gold Miner Diagnosed in French Guiana
- Author
-
Melzani, Alessia, primary, Boutrou, Mathilde, additional, Sainte-Rose, Vincent, additional, About, Frédégonde, additional, Douine, Maylis, additional, Michaud, Céline, additional, Nacher, Mathieu, additional, Gaillet, Mélanie, additional, Blanchet, Denis, additional, Lavigne, Jean Philippe, additional, Demar, Magalie, additional, O’Callaghan, David, additional, Djossou, Felix, additional, Keriel, Anne, additional, and Epelboin, Loïc, additional
- Published
- 2023
- Full Text
- View/download PDF
6. A severe case of Plasmodium falciparum malaria imported by a French traveler from Cameroon to French Guiana despite regular intake of Artemisia annua herbal tea
- Author
-
Cohen, Olivia, primary, Boutrou, Mathilde, additional, Nacher, Mathieu, additional, Caumes, Eric, additional, Djossou, Félix, additional, and Epelboin, Loïc, additional
- Published
- 2023
- Full Text
- View/download PDF
7. Panorama des pathologies infectieuses et non infectieuses de Guyane en 2022
- Author
-
EPELBOIN, Loïc, ABBOUD, Philippe, ABDELMOUMEN, Karim, ABOUT, Frédégonde, ADENIS, Antoine, BLAISE, Théo, BLAIZOT, Romain, BONIFAY, Timothée, BOURNE-WATRIN, Morgane, BOUTROU, Mathilde, CARLES, Gabriel, CARLIER, Pierre-Yves, CAROD, Jean-François, CARVALHO, Luisiane, COUPPIÈ, Pierre, DE TOFFOL, Bertrand, DELON, François, DEMAR, Magalie, DESTOOP, Justin, DOUINE, Maylis, DROZ, Jean-Pierre, ELENGA, Narcisse, ENFISSI, Antoine, FRANCK, Yves-Kénol, FREMERY, Alexis, GAILLET, Mélanie, KALLEL, Hatem, KPANGON, Arsène Amadouhé, LAVERGNE, Anne, LE TURNIER, Paul, MAISONOBE, Lucas, MICHAUD, Céline, MUTRICY, Rémi, NACHER, Mathieu, NALDJINAN-KODBAYE, Richard, OBERLIS, Margot, ODONNE, Guillaume, OSEI, Lindsay, PUJO, Jean, RABIER, Sébastien, ROMAN-LAVERDURE, Brigitte, ROUSSEAU, Cyril, ROUSSET, Dominique, SABBAH, Nadia, SAINTE-ROSE, Vincent, SCHAUB, Roxane, SYLLA, Karamba, TAREAU, Marc-Alexandre, TERTRE, Victor, THOREY, Camille, VIALETTE, Véronique, WALTER, Gaëlle, Magaly, Magaly, DJOSSOU, Félix, and VIGNIER, Nicolas
- Abstract
Overview of infectious and non-infectious diseases in French Guiana in 2022 Source of many myths, French Guiana represents an exceptional territory due to the richness of its biodiversity and the variety of its communities. The only European territory in Amazonia, surrounded by the Brazilian giant and the little-known Suriname, Ariane 6 rockets are launched from Kourou while 50% of the population lives below the poverty line. This paradoxical situation is a source of health problems specific to this territory, whether they be infectious diseases with unknown germs, intoxications or chronic pathologies. Some infectious diseases such as Q fever, toxoplasmosis, cryptococcosis or HIV infection are in common with temperate countries, but present specificities leading to sometimes different management and medical reasoning. In addition to these pathologies, many tropical diseases are present in an endemic and / or epidemic mode such as malaria, leishmaniasis, Chagas disease, histoplasmosis or dengue. Besides, Amazonian dermatology is extremely varied, ranging from rare but serious pathologies (Buruli ulcer, leprosy) to others which are frequent and benign such as agouti lice (mites of the family Trombiculidae) or papillonitis. Envenomations by wild fauna are not rare, and deserve an appropriate management of the incriminated taxon. Obstetrical, cardiovascular and metabolic cosmopolitan pathologies sometimes take on a particular dimension in French Guiana that must be taken into account in the management of patients. Finally, different types of intoxication are to be known by practitioners, especially due to heavy metals. European-level resources offer diagnostic and therapeutic possibilities that do not exist in the surrounding countries and regions, thus allowing the management of diseases that are not well known elsewhere. Thanks to these same European-level resources, research in Guyana occupies a key place within the Amazon region, despite a smaller population than in the surrounding countries. Thus, certain pathologies such as histoplasmosis of the immunocompromised patient, Amazonian toxoplasmosis or Q fever are hardly described in neighboring countries, probably due to under-diagnosis linked to more limited resources. French Guiana plays a leading role in the study of these diseases. The objective of this overview is to guide health care providers coming to or practicing in French Guiana in their daily practice, but also practitioners taking care of people returning from French Guiana. Panorama des pathologies infectieuses et non infectieuses de Guyane en 2022 Source de nombreux mythes, la Guyane représente un territoire exceptionnel par la richesse de sa biodiversité et par la variété des communautés qui la composent. Seul territoire européen en Amazonie, entouré du géant brésilien et du méconnu Suriname, on y lance des fusées Ariane 6 depuis Kourou tandis que 50 % de la population vit en dessous du seuil de pauvreté. Cette situation paradoxale est source de problématiques de santé spécifiques à ce territoire, qu’il s’agisse de maladies infectieuses à germes méconnus, d’intoxications, ou de pathologies chroniques. Certaines maladies infectieuses telles que la fièvre Q, la toxoplasmose, la cryptococcose ou l’infection à VIH sont communes aux pays tempérés, mais présentent en Guyane des spécificités entraînant une prise en charge et un raisonnement médical parfois différents. Parallèlement à ces pathologies, de nombreuses maladies tropicales sont par ailleurs présentes sur un mode endémique et / ou épidémique telles que le paludisme, la leishmaniose, la maladie de Chagas, l’histoplasmose ou la dengue. De plus, la dermatologie amazonienne est extrêmement variée, allant de pathologies rares, mais graves (ulcère de Buruli, lèpre), à d’autres fréquentes et bénignes telles que les poux d’agouti (acariens de la famille des Trombiculidae) ou la papillonite. Les envenimations par la faune sauvage ne sont pas rares, et méritent une prise en charge appropriée au taxon incriminé. Les pathologies obstétricale, cardiovasculaire et métabolique cosmopolites prennent parfois en Guyane une dimension particulière à prendre en compte dans la prise en charge des patients. Enfin, différents types d’intoxication sont à connaître par les praticiens, notamment aux métaux lourds. Les ressources de niveau européen offrent des possibilités diagnostiques et thérapeutiques inexistantes dans les pays et régions des environs, permettant ainsi la prise en charge de maladies peu connues ailleurs. Du fait de ces mêmes ressources de niveau européen, la recherche en Guyane occupe une place clé au sein de la région amazonienne, malgré une population moins nombreuse que dans les pays alentour. Ainsi, certaines pathologies telles que l’histoplasmose du patient immunodéprimé, la toxoplasmose amazonienne ou la fièvre Q ne sont pratiquement pas décrites dans les pays voisins, probablement du fait d’un sous-diagnostic lié à des ressources plus limitées. La Guyane joue ainsi un rôle moteur dans l’étude de ces pathologies. L’objectif de ce panorama est d’orienter les soignants venant ou exerçant en Guyane dans leur pratique quotidienne, mais également les praticiens prenant en charge des personnes au retour de Guyane., MTSI, Vol. 3 No 1 (2023): MTSI-Revue
- Published
- 2023
- Full Text
- View/download PDF
8. A severe case of Plasmodium falciparum malaria imported by a French traveler from Cameroon to French Guiana despite regular intake of Artemisia annua herbal tea
- Author
-
Cohen, Olivia, Boutrou, Mathilde, Nacher, Mathieu, Caumes, Eric, Djossou, Félix, and Epelboin, Loïc
- Subjects
Severe malaria ,Amazonia ,Prophylaxis ,Herbal tea ,Plasmodium falciparum ,Artemisia annua - Abstract
The use of herbal tea with Artemisia annua by travelers and traditional communities in Africa has increased in recent years as a supposed form of malaria prophylaxis, although its use is not recommended due to lack of efficacy. The risk of severe malaria complications that can lead to death is real regarding said behavior, and awareness needs to be raised. We report a case of severe Plasmodium falciparum malaria imported in the Amazon rainforest by a traveler returning from Cameroon who treated himself with Artemisia annua herbal tea.
- Published
- 2023
9. Staphylococcus aureus endocarditis: Identifying prognostic factors using a method derived from morbidity and mortality conferences
- Author
-
Lefèvre, Benjamin, primary, Legoff, Antoine, additional, Boutrou, Mathilde, additional, Goehringer, François, additional, Ngueyon-Sime, Willy, additional, Chirouze, Catherine, additional, Revest, Matthieu, additional, Vernet Garnier, Véronique, additional, Duval, Xavier, additional, Delahaye, François, additional, Le Moing, Vincent, additional, Selton-Suty, Christine, additional, Filippetti, Laura, additional, Hoen, Bruno, additional, and Agrinier, Nelly, additional
- Published
- 2022
- Full Text
- View/download PDF
10. 5e journée des travaux scientifiques des soignants de Guyane. Nos soignants ont du talent ! 19 & 20 mai 2022, Cayenne, Guyane
- Author
-
LUCARELLI, Aude, HUREAU-MUTRICY, Louise, SOLIGNAT, Blandine, BOURNE-WATRIN, Morgane, BLAISE, Théo, OSEI, Lindsay, COUSIN, Pauline, BOUTROU, Mathilde, DESTOOP, Justin, Alexis, Alexis, MUTRICY, Rémi, BONIFAY, Timothée, and EPELBOIN, Loïc
- Abstract
Ces 19 et 20 mai 2022 se sont tenues à Cayenne, en Guyane, les 5e journées des travaux scientifiques des soignants de Guyane « Nos soignants ont du talent ». Ces dernières ont remplacé depuis 2021 les Journées des travaux scientifiques des jeunes médecins de Guyane « Nos internes ont du talent », en s’ouvrant largement à d’autres corps de métier de la santé. Ainsi, lors de cette nouvelle session, 10 infirmières, 4 sages-femmes, 1 pharmacienne, 1 technicienne de laboratoire et 22 médecins ont contribué aux communications orales et affichées de ces journées. Les sujets abordés ont touché des domaines extrêmement variés, avec des travaux concernant les zoonoses (rage, fièvre Q), les interactions entre l’homme avec la faune sauvage (envenimation par la faune sauvage, en particulier ophidienne), la santé publique en zone isolée (Covid, VIH, paludisme), l’épidémiologie tropicale (hémopathies liées à l’HTLV, histoplasmose pulmonaire, toxoplasmose, tuberculose, fièvre jaune), la dermatologie tropicale (prurigo du VIH, dermo-hypodermites, dermatologie en zone isolée, leishmaniose cutanée), la périnatalité (exposition au plomb chez les femmes enceintes, causes de mort fœtale in utero, dépistage du cancer du col de l’utérus), la santé notamment sexuelle, mais aussi globale et addictive de différentes populations (orpailleurs clandestins, populations incarcérées, femmes migrantes, agriculteurs), les pathologies cardiovasculaires et les hémoglobinopathies (diabète, AVC, drépanocytose), la prise en charge des violences (épidémiologie des plaies par arme à feu, violences sexuelles et conjugales), la mise en place de projets en santé communautaire dans les quartiers défavorisés (Covid, eau-hygiène-assainissement), les soins et patients (interculturalité, barrière de la langue, EVASAN). Ces journées se sont tenues pour la deuxième fois en format mixte présentiel et/ou distanciel, avec environ 200 participants chaque jour qui ont assisté aux présentations et contribué aux débats. Enfin, le retour sur les années précédentes a montré que les travaux présentés lors de ces journées de Guyane sont loin d’être limités en termes d’intérêt scientifique à la sphère locale « guyano-guyanaise ». En effet, un pourcentage non négligeable des présentations réalisées ces dernières années a fait l’objet de publications dans des journaux internationaux principalement anglophones – 16/19 (84 %) en 2017, 9/28 (32 %) en 2018, 8/25 (32 %) en 2019 et 10/25 (40 %) en 2021. Tous les organisateurs de ces journées originales espèrent que l’implication et l’engouement des soignants pour la recherche scientifique se poursuivent, et connaissent une importance grandissante lors des sessions à venir., MTSI, Vol. 2 No 2 (2022): MTSI-Revue
- Published
- 2022
- Full Text
- View/download PDF
11. A Simple Predictive Score to Distinguish between Disseminated Histoplasmosis and Tuberculosis in Patients with HIV
- Author
-
Nacher, Mathieu, primary, Drak Alsibai, Kinan, additional, Epelboin, Loïc, additional, Abboud, Philippe, additional, About, Frédégonde, additional, Demar, Magalie, additional, Djossou, Félix, additional, Blaizot, Romain, additional, Douine, Maylis, additional, Sabbah, Nadia, additional, Vignier, Nicolas, additional, Adriouch, Leila, additional, Lucarelli, Aude, additional, Boutrou, Mathilde, additional, Couppié, Pierre, additional, and Adenis, Antoine, additional
- Published
- 2021
- Full Text
- View/download PDF
12. High-risk exposure without personal protective equipment and infection with SARS-CoV-2 in-hospital workers - The CoV-CONTACT cohort
- Author
-
Tubiana, Sarah, Burdet, Charles, Houhou, Nadhira, Thy, Michael, Manchon, Pauline, Blanquart, François, Charpentier, Charlotte, Guedj, Jérémie, Alavoine, Loubna, Behillil, Sylvie, Leclercq, Anne, Lucet, Jean-Christophe, Yazdanpanah, Yazdan, Attia, Mikaël, Demeret, Caroline, Rose, Thierry, Bielicki, Julia Anna, Bruijning-Verhagen, Patricia, Goossens, Herman, Descamps, Diane, van der Werf, Sylvie, Lina, Bruno, Duval, Xavier, Abad, Fanny, Abry, Dominique, Allain, Jean-Sébastien, Amiel-Taieb, Karline, Audoin, Pierre, Augustin, Shana, Ayala, Sandrine, Bansard, Hélène, Bertholon, Fréderique, Boissel, Nolwenn, Botelho-Nevers, Elisabeth, Bouiller, Kévin, Bourgeon, Marilou, Boutrou, Mathilde, Brick, Lysiane, Bruneau, Léa, Caumes, Eric, Chabouis, Agnès, Chan Thien, Eric, Chirouze, Catherine, Coignard, Bruno, Costa, Yolande, Costenoble, Virginie, Cour, Sylvie, Cracowski, Claire, Cracowski Jean, Luc, Deplanque, Dominique, Dequand, Stéphane, Desille-Dugast, Mireille, Desmarets, Maxime, Detoc, Maelle, Dewitte, Marie, Djossou, Felix, Ecobichon, Jean-Luc, Elrezzi, Elise, Faurous, William, Fortuna, Viviane, Fouchard, Julie, Gantier, Emilie, Gautier, Céline, Gerardin, Patrick, Gerset, Sandrine, Gilbert, Marie, Gissot, Valérie, Guillemin, Francis, Hartard, Cédric, Hazevis, Béatrice, Hocquet, Didier, Hodaj, Enkelejda, Ilic-Habensus, Emila, A, Jeudy, Jeulin, Helene, Kane, Maty, Kasprzyk, Emmanuelle, Kikoine, John, Laine, Fabrice, Laviolle, Bruno, Lebeaux, David, Ledru, Eric, Lefevre, Benjamin, Legoas, Carole, Legrand, Amélie, Legrand, Karine, Lehacaut, Jonathan, Lehur, Claire, Lemouche, Dalila, Lepiller, Quentin, Lepuil, Sévérine, Letienne, Estelle, Lucarelli, Aude, Madeline, Isabelle, Maillot, Adrien, Malapate, Catherine, Malvy, Denis, Mandic, Milica, Marty-Quinternet, Solène, Meghadecha, Mohamed, Mergeay-Fabre, Mayka, Mespoulhe, Pauline, Meunier, Alexandre, Migaud, Maria-Claire, Motiejunaite, Justina, Nathalie, Gay, Nguyen, Duc, Oubbea, Soumaya, Pagadoy, Maïder, Paris, Adeline, Paris, Christophe, Payet, Christine, Peiffer-Smadja, Nathan, Perez, Lucas, Perreau, Pauline, Pierrez, Nathalie, Pistone, Thierry, Postolache, Andreea, Rasoamanana, Patrick, Reminiac, Cécile, Rexah, Jade, Roche-Gouanvic, Elise, Rousseau, Alexandra, Schoemaecker, Betty, Simon, Sandrine, Soler, Catherine, Somers, Stéphanie, Sow, Khaly, Tardy, Bernard, Terzian, Zaven, Tournier, Anne, Tyrode, Sandrine, Vauchy, Charline, Verdon, Renaud, Vernet, Pauline, Vignali, Valérie, Waucquier, Nawal, Do Thi Thu, Huong, Laouénan, Cédric, Mentre, France, Pauline, Manchon, Dechanet, Aline, Letrou, Sophie, Quintin, Caroline, Frezouls, Wahiba, Le Hingrat, Quentin, Damond, Florence, Descamps, Dianes, Visseaux, Benoit, Vabret, Astrid, Bouscambert, Maud, Gaillanne, Laurence, Benmalek, Nabil, Attia, Mikael, Barbet, Marion, Petres, Stéphane, Escriou, Nicolas, Goyard, Sophie, Kafif, Ouifiya, Piquard, Valentine, Mailles, Alexandra, Simondon, Anne, Dreyere, Marion, Morel, Bruno, Vesval, Thiphaine, Amat, Karine, Ammour, Douae, Aqourras, Khadija, Couffin-Cadiergues, Sandrine, Delmas, Christelle, Desan, Vristi, Jean, Michel Doute, Esperou, Hélène, Hendou, Samia, Kouakam, Christelle, Le Meut, Guillaume, Lemestre, Soizic, Leturque, Nicolas, Marcoul, Emmanuelle, Nguefang, Solange, Roufai, Layidé, Abel, Laurent, Caillat-Zucman, Sophie, Study Group, Covcontact, Centre d'investigation Clinique [CHU Bichat] - Épidémiologie clinique (CIC 1425), AP-HP - Hôpital Bichat - Claude Bernard [Paris], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Institut National de la Santé et de la Recherche Médicale (INSERM), Infection, Anti-microbiens, Modélisation, Evolution (IAME (UMR_S_1137 / U1137)), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité)-Université Sorbonne Paris Nord, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Centre interdisciplinaire de recherche en biologie (CIRB), Labex MemoLife, École normale supérieure - Paris (ENS-PSL), Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Collège de France (CdF (institution))-Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI Paris), Université Paris sciences et lettres (PSL)-École normale supérieure - Paris (ENS-PSL), Université Paris sciences et lettres (PSL)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Génétique Moléculaire des Virus à ARN - Molecular Genetics of RNA Viruses (GMV-ARN (UMR_3569 / U-Pasteur_2)), Institut Pasteur [Paris] (IP)-Centre National de la Recherche Scientifique (CNRS)-Université Paris Cité (UPCité), Centre National de Référence des virus des infections respiratoires (dont la grippe) - National Reference Center Virus Influenzae [Paris] (CNR - laboratoire coordonnateur), Institut Pasteur [Paris] (IP), Hôpital Beaujon [AP-HP], Physique des fonctions biologiques / Physics of Biological Functions, Institut Pasteur [Paris] (IP)-Centre National de la Recherche Scientifique (CNRS), Biologie Cellulaire des Lymphocytes - Lymphocyte Cell Biology, Institut Pasteur [Paris] (IP)-Institut National de la Santé et de la Recherche Médicale (INSERM), St George's, University of London, University Children’s Hospital Basel = Hôpital pédiatrique universitaire des deux Bâle [Bâle, Suisse] (UKBB), University Medical Center [Utrecht], Universiteit Antwerpen = University of Antwerpen [Antwerpen], Virology and human respiratory Pathologies - Virology and human respiratory Pathologies (VirPath), Centre International de Recherche en Infectiologie (CIRI), École normale supérieure de Lyon (ENS de Lyon)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Université Jean Monnet - Saint-Étienne (UJM)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-École normale supérieure de Lyon (ENS de Lyon)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Université Jean Monnet - Saint-Étienne (UJM)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Centre National de Référence des Virus des Infections Respiratoires (dont la Grippe) [Lyon] (CNR - laboratoire associé), Institut des Agents Infectieux [Lyon] (IAI), Hospices Civils de Lyon (HCL)-Hospices Civils de Lyon (HCL), CHU Pontchaillou [Rennes], Institut de recherche en santé, environnement et travail (Irset), Université d'Angers (UA)-Université de Rennes (UR)-École des Hautes Études en Santé Publique [EHESP] (EHESP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Structure Fédérative de Recherche en Biologie et Santé de Rennes ( Biosit : Biologie - Santé - Innovation Technologique ), ANR-20-COVI-0002,CORaDiag,COVID 19 Rapid diagnosis test (development and clinical validation in 7 weeks)(2020), École normale supérieure - Paris (ENS Paris), Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI Paris), Université Paris sciences et lettres (PSL)-Collège de France (CdF (institution))-École normale supérieure - Paris (ENS Paris), Université Paris sciences et lettres (PSL)-Collège de France (CdF (institution))-Centre National de la Recherche Scientifique (CNRS)-Institut National de la Santé et de la Recherche Médicale (INSERM), and Université Paris sciences et lettres (PSL)-Collège de France (CdF (institution))-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)
- Subjects
Microbiology (medical) ,medicine.medical_specialty ,2019-20 coronavirus outbreak ,Coronavirus disease 2019 (COVID-19) ,Health Personnel ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,[SDV]Life Sciences [q-bio] ,Pneumonia, Viral ,Sars-cov-2 ,Betacoronavirus ,03 medical and health sciences ,Health personnel ,0302 clinical medicine ,High-risk exposure ,[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases ,Personal protective equipment ,medicine ,Humans ,Risk exposure ,Transmission ,030212 general & internal medicine ,Letter to the Editor ,Pandemics ,ComputingMilieux_MISCELLANEOUS ,0303 health sciences ,030306 microbiology ,Transmission (medicine) ,business.industry ,COVID-19 ,3. Good health ,Infectious Diseases ,Cohort ,Emergency medicine ,In-hospital workers ,Human medicine ,Coronavirus Infections ,business - Abstract
International audience
- Published
- 2021
- Full Text
- View/download PDF
13. Detection of SARS-CoV-2 N-antigen in blood during acute COVID-19 provides a sensitive new marker and new testing alternatives
- Author
-
Marcoul Emmanuelle, Benoit Visseaux, Minh Patrick Lê, Alphonsine Diouf, Mergeay-Fabre Mayka, Kasprzyk Emmanuelle, Hazevis Beatrice, Houhou Nadhira, Christophe Choquet, Laviolle Bruno, Benedicte Rossignol, Verdon Renaud, Aqourras Khadija, Bourgeon Marilou, Lehur Claire, Ikram Houas, Ventzislava Petrov-Sanchez, Jeremie Guedj, Aurelie Veislinger, Amina Meziane, Brick Lysiane, Salma Jaafoura, Alexandre Hoctin, Visseaux Benoit, Oriane Puéchal, Alavoine Loubna, Denis Malvy, Gautier Celine, Letienne Estelle, Djossou Felix, Amiel-Taieb Karline, Esperou Helene, Thy Michael, Alpha Diallo, Bertholon Frederique, Sow Khaly, Boutrou Mathilde, Somers Stephanie, Tardy Bernard, Descamps Dianes, Rose Thierry, Morgane Gilg, Lucarelli Aude, Kikoine John, Charles Burdet, Barbet Marion, Kafif Ouifiya, Yazdan Yazdanpanah, Perez Lucas, Justine Pages, Laurent Abel, Florence Damond, Kouakam Christelle, Guillemin Francis, Dominique Deplanque, Marie Pierre Debray, Camille Couffignal, Botelho-Nevers Elisabeth, Jean Sebastien Hulot, Desmarets Maxime, Meunier Alexandre, Legrand Amelie, Maillot Adrien, Marine Beluze, Hartard Cedric, Bansard Helene, Legoas Carole, Gantier Emilie, Ledru Eric, Noemie Mercier, Sylvie van der Werf, Philippine Eloy, Guillaume Lingas, Coralie Tardivon, Fouchard Julie, Dewitte Marie, Bruno Lina, Alexandra Coelho, Boissel Nolwenn, Demeret Caroline, Marty-Quinternet Solene, Cédric Laouénan, Nassima Si Mohammed, Meghadecha Mohamed, Reminiac Cecile, Isabelle Gorenne, Chabouis Agnes, Paris Adeline, Sabrina Kali, Pierrez Nathalie, Mathilde Desvallee, Cracowski Jean Luc, Nathan Peiffer-Smadja, Tournier Anne, Abry Dominique, Marina Esposito-Farese, Lucet Jean-Christophe, Tristan Gigante, Abad Fanny, Olivier Picone, Lefevre Benjamin, Soizic Le Mestre, Ecobichon Jean-Luc, Manuel Rosa-Calatrava, Morel Bruno, Leturque Nicolas, Nguyen Duc, Nathalie Gault, Simon Sandrine, Jade Ghosn, Letrou Sophie, Elrezzi Elise, Ilic-Habensus Emila, Hodaj Enkelejda, Quintin Caroline, Doute Jean Michel, Schoemaecker Betty, Escriou Nicolas, Francois Dubos, A. Jeudy, Gilles Peytavin, Nadhira Houhou-Fidouh, Aurelie Papadopoulos, Noemie Vanel, Aurélie Wiedemann, Vincent Enouf, Rasoamanana Patrick, Behillil Sylvie, Le Hingrat Quentin, Vernet Pauline, Eric D'Ortenzio, Couffin-Cadiergues Sandrine, Damond Florence, Rousseau Alexandra, Jimmy Mullaert, Lemestre Soizic, Cracowski Claire, Malapate Catherine, Hocquet Didier, Francois Teoule, Hervé Le Nagard, Krishna Bhavsar, Mandic Milica, Postolache Andreea, Yves Levy, Caroline Semaille, Perreau Pauline, Frezouls Wahiba, Malvy Denis, Bouscambert Maud, Nadège Néant, Soler Catherine, Dreyere Marion, Nabil Benmalek, Diane Descamps, Allain Jean-Sebastien, Gerardin Patrick, Lila Bouadma, Charlotte Charpentier, Roufai Layide, Caillat-Zucman Sophie, Sandrine Couffin-Cardiergues, Sylvie Behilill, François Angoulvant, Coignard Bruno, Marina Mambert, Petres Stephane, Jean-François Timsit, Dehbia Benkerrou, Coralie Khan, Goyard Sophie, Motiejunaite Justina, Le Meut Guillaume, Burdet Charles, Christelle Paul, Catherine Chirouze, Pagadoy Maider, Hugo Mouquet, Hendou Samia, Fortuna Viviane, Dechanet Aline, Claire Andrejak, Marion Schneider, Claire Levy-Marchal, Christelle Tual, Olivier Terrier, Gerset Sandrine, J.-C. Lucet, Ammour Douae, Quentin Le Hingrat, Madeline Isabelle, Piquard Valentine, Costenoble Virginie, Paris Christophe, Lepiller Quentin, Manuel Etienne, Vignali Valerie, Oubbea Soumaya, Kane Maty, Hélène Espérou, François-Xavier Lescure, Desan Vristi, Vauchy Charline, Francois Bompart, Simondon Anne, Xavier Duval, Delphine Bachelet, Tyrode Sandrine, Rexah Jade, Bruneau Lea, Carine Roy, Gilbert Marie, Amat Karine, Augustin Shana, Gissot Valerie, Lehacaut Jonathan, Do Thi Thu Huong, Antoine Khalil, Marie Capucine Tellier, Pauline Manchon, Ouifiya Kafif, Bouiller Kevin, Jeulin Helene, Faurous William, Tubiana Sarah, Cour Sylvie, Detoc Maelle, Van Der Werf Sylvie, Mailles Alexandra, Audoin Pierre, Nguefang Solange, Mespoulhe Pauline, Caumes Eric, Alexandre Gaymard, Pistone Thierry, Laouenan Cedric, Delmas Christelle, Lepuil Severine, Ayala Sandrine, Lemouche Dalila, Dequand Stephane, Céline Dorival, Lina Bruno, Minerva Cervantes-Gonzalez, Duval Xavier, Costa Yolande, Leclercq Anne, Vabret Astrid, Theo Trioux, Samira Laribi, Roche-Gouanvic Elise, Houria Ichou, Deplanque Dominique, Isabelle Hoffmann, Marion Noret, Benmalek Nabil, Gaillanne Laurence, Mélanie Bertine, Lysa Tagherset, Peiffer-Smadja Nathan, Migaud Maria-Claire, Waucquier Nawal, Desille-Dugast Mireille, Nadia Ettalhaoui, Sarah Tubiana, Payet Christine, Romain Basmaci, Laine Fabrice, Attia Mikael, Patrick Rossignol, Charlene Da Silveira, Legrand Karine, Florentia Kaguelidou, Chirouze Catherine, Chan Thien Eric, Lebeaux David, Maude Bouscambert, Vesval Thiphaine, Charpentier Charlotte, Terzian Zaven, Infection, Anti-microbiens, Modélisation, Evolution (IAME (UMR_S_1137 / U1137)), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité)-Université Sorbonne Paris Nord, AP-HP - Hôpital Bichat - Claude Bernard [Paris], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Centre d'Investigation Clinique [Rennes] (CIC), Université de Rennes (UR)-Hôpital Pontchaillou-Institut National de la Santé et de la Recherche Médicale (INSERM), Institut Pasteur [Paris] (IP), Qiagen, BioMérieux, Gilead, Theratechnologie, Hologic, ViiV Healthcare, Abbvie, BMS, J&J, Pfizer, Beckton Dickinson, REACTing, 20-0424, Ministry of Health, ANRS, AAZ, Inserm, Sanofi Pasteur, Da Volterra, Biomerieux, Mylan, MSD, Medimune, Gilead Sciences, Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Paris (UP)-Université Sorbonne Paris Nord, Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-Hôpital Pontchaillou-Institut National de la Santé et de la Recherche Médicale (INSERM), and Jonchère, Laurent
- Subjects
0301 basic medicine ,Microbiology (medical) ,Serum ,medicine.medical_specialty ,Saliva ,Coronavirus disease 2019 (COVID-19) ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,[SDV]Life Sciences [q-bio] ,030106 microbiology ,Antigenemia ,Gastroenterology ,03 medical and health sciences ,Plasma ,0302 clinical medicine ,Antigen ,Internal medicine ,Medicine ,Sampling (medicine) ,030212 general & internal medicine ,Symptom onset ,Diagnostic ,business.industry ,SARS-CoV-2 ,COVID-19 ,General Medicine ,Serum samples ,3. Good health ,[SDV] Life Sciences [q-bio] ,Research Note ,Infectious Diseases ,Blood ,business ,Viral load - Abstract
Objectives Molecular assays on nasopharyngeal swabs remain the cornerstone of COVID-19 diagnostics. The high technicalities of nasopharyngeal sampling and molecular assays, as well as scarce resources of reagents, limit our testing capabilities. Several strategies failed, to date, to fully alleviate this testing process (e.g. saliva sampling or antigen testing on nasopharyngeal samples). We assessed the clinical performances of SARS-CoV-2 nucleocapsid antigen (N-antigen) ELISA detection in serum or plasma using the COVID-19 Quantigene® (AAZ, France) assay. Methods Performances were determined on 63 serum samples from 63 non-COVID patients and 227 serum samples (165 patients) from the French COVID and CoV-CONTACT cohorts with RT-PCR-confirmed SARS-CoV-2 infection, including 142 serum samples (114 patients) obtained within 14 days after symptom onset. Results Specificity was 98.4% (95% CI 95.3–100). Sensitivity was 79.3% overall (180/227, 95% CI, 74.0–84.6) and 93.0% (132/142, 95% CI, 88.7–97.2) within 14 days after symptom onset. Ninety-one of the included patients had serum samples and nasopharyngeal swabs collected in the same 24 hr. Among those with high nasopharyngeal viral loads, i.e. Ct value below 30 and 33, only 1/50 and 4/67 tested negative for N-antigenaemia, respectively. Among those with a negative nasopharyngeal RT-PCR, 8/12 presented positive N-antigenaemia; the lower respiratory tract was explored for six of these eight patients, showing positive RT-PCR in five cases. Discussion This is the first evaluation of a commercially available serum N-antigen detection assay. It presents a robust specificity and sensitivity within the first 14 days after symptoms onset. This approach provides a valuable new option for COVID-19 diagnosis, only requiring a blood draw and easily scalable in all clinical laboratories.
- Published
- 2021
14. Analyse qualitative des causes et circonstances de décès dans l'endocardite infectieuse à Staphylococcus aureus : étude de 57 dossiers de patients décédés
- Author
-
Boutrou, Mathilde, Université des Antilles - UFR des sciences médicales Hyacinthe Bastaraud (UA UFR SM), Université des Antilles (UA), Bruno Hoen, and BHU, Fort de France
- Subjects
[SDV.MHEP] Life Sciences [q-bio]/Human health and pathology ,Staphylococcus Aureus ,Endocardite infectieuse ,[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology - Abstract
Introduction - Staphylococcus aureus (SA) is the leading cause of infectious endocarditis (IE) and in comparison with other microorganisms, it provokes more serious infections with a higher mortality. Prognostic factors for SAIE are already known but they are not different from those reported for other IE and cannot to explain the excess of mortality. The main aim of this study was to inventory the causes of death of SAIE and second to identify new potential prognostic factors.Patients and methods - We conducted a retrospective qualitative study on all the patients who died during their hospitalization for SAIE in 2008 in 7 administrative regions of France. The qualitative analysis permitted to determine individually the final cause of death and to identify elements from patient characteristics, from the severity of the initial presentation, and from the care received. Then, those elements were selected and collected for each patient. Results - 57 patients were included. The mean age was 67,2 years (+/-16,1 Standard Deviation (SD)). The mean Charlson score was 2,5. The main final causes of death were cardiogenic choc, septic choc and neurologic causes (respectively 19, 17 and 15 patients). The other causes were acute respiratory distress syndrome (7), intraoperative death (4), hepatic insufficiency (3), final renal failure (3), mesenteric infarction (1), acute ischemia of a member (1) and slipping syndrome (1). The cause was composite in 10 cases. New elements related to the patient specificity were dependence (8 patients), pressure ulcer (8 patients) and malnutrition (20 patients). Another eight were treated by non-steroïdal anti- inflammatory drug before admission. About the gravity of the initial presentation, 18 patients had thrombocytopenia < 100 giga per liter. Eight patients had lactate over 2,5 mmol per liter. Respectively 24 (46%) and 12 patients (22,6%) needed vasopressive amines or dobutamine. During hospitalization, the empirical treatment was efficient in 40 patients on the 49 treated and included the optimal antibiotic in 11 cases. The mean time before starting documented antibiotic therapy was 5,2 days (+/-9,1 SD). The molecule and dose of this antibiotic therapy complied with the European standards in 27 cases. On the 35 patients who had an indication for cardiac surgery, only 16 patients undergo surgery. The main cause for lack of surgery was the poor condition of the patient (25,7%). Another surgery was indicated in 15 patient and it was neurosurgery in 33% of the cases. Respectively 17 and 19 patients presented a nosocomial infection or an iatrogenic complication during their hospitalization. It was drug toxicity in 14 cases and iatrogenic events in 12 cases, including skill complications, anticoagulant-linked hemorrhages.Conclusion - This qualitative study show that the main causes of death of the patient with SAIE are cardiogenic choc, neurologic causes and septic choc. It also highlight several potential prognostic factors that should be specifically studied: non-steroidal anti-inflammatory drugs, thrombocytopenia, concordance of antibiotic treatment to the microorganism and to recommendations, respect of surgical indication and occurrence of iatrogenic events., Introduction. Les endocardites à Staphylococcus aureus (ESA) sont les plus fréquentes, les plus graves et celles ayant la mortalité la plus élevée des endocardites. Leurs facteurs pronostiques sont identifiés mais ne diffèrent pas de ceux rapportés pour les autres endocardites et n’expliquent la surmortalité observée. L’objectif principal de cette étude était de recenser les causes de mortalité des ESA et secondairement d’identifier de nouveaux facteurs potentiellement liés à la mortalité. Patients et méthodes. Cette étude rétrospective qualitative porte sur 57 patients décédés pendant leur hospitalisation d’ESA au cours de l’année 2008 dans 7 régions de France. L’analyse qualitative des dossiers permettait une analyse approfondie des éléments pouvant avoir un lien avec la mortalité.Résultats. La moyenne d’âge des patients était de 67,2 ans (+/-16,1). Les principales causes de décès étaient le choc cardiogénique, le choc septique, et les causes neurologiques (15 patients chacun soit 26,3%). Les autres causes de décès étaient le syndrome de détresse respiratoire aigu (7), le décès peropératoire (4), l’insuffisance hépatocellulaire (3), l’insuffisance rénale terminale (3), l’infarctus mésentérique (1), l’ischémie aigue de membre (1) et le syndrome de glissement (1). Huit patients étaient traités par anti-inflammatoire non stéroïdien (AINS). Dix-huit patients avaient une thrombopénie. L’antibiothérapie documentée était initiée en moyenne 5,2 jours (+/- 9,1) après le diagnostic et était conforme aux recommandations dans 27 cas (57%). Sur les 35 patients présentant une indication de chirurgie cardiaque, 16 patients ont été opérés. Au total 29 patients ont présenté une complication iatrogène dont 17 infections nosocomiales et 14 événements iatrogènes médicamenteux. Conclusion. Les principales causes de décès des patients atteints d’ESA sont le choc cardiogénique, les causes neurologiques et le choc septique. Plusieurs éléments sont potentiellement associés au décès : les AINS, la thrombopénie, l’inadéquation des antibiotiques aux recommandations, le non-respect de l’indication chirurgicale et les complications iatrogènes.
- Published
- 2018
15. A Simple Predictive Score to Distinguish between Disseminated Histoplasmosis and Tuberculosis in Patients with HIV.
- Author
-
Nacher, Mathieu, Drak Alsibai, Kinan, Epelboin, Loïc, Abboud, Philippe, About, Frédégonde, Demar, Magalie, Djossou, Félix, Blaizot, Romain, Douine, Maylis, Sabbah, Nadia, Vignier, Nicolas, Adriouch, Leila, Lucarelli, Aude, Boutrou, Mathilde, Couppié, Pierre, and Adenis, Antoine
- Subjects
HISTOPLASMOSIS ,TUBERCULOSIS ,HIV-positive persons ,DIFFERENTIAL diagnosis ,PROBABILITY theory - Abstract
Disseminated histoplasmosis is a common differential diagnosis of tuberculosis in disease-endemic areas. We aimed to find a predictive score to orient clinicians towards disseminated histoplasmosis or tuberculosis when facing a non-specific infectious syndrome in patients with advanced HIV disease. We reanalyzed data from a retrospective study in Cayenne Hospital between January 1997–December 2008 comparing disseminated histoplasmosis and tuberculosis: 100 confirmed disseminated histoplasmosis cases and 88 confirmed tuberculosis cases were included. A simple logit regression model was constructed to predict whether a case was tuberculosis or disseminated histoplasmosis. From this model, a score may be obtained, where the natural logarithm of the probability of disseminated histoplasmosis/tuberculosis = +3.917962 × WHO performance score (1 if >2, 0 if ≤2) −1.624642 × Pulmonary presentation (1 yes, 0 no) +2.245819 × Adenopathies > 2 cm (1 yes, 0 no) −0.015898 × CD4 count − 0.001851 × ASAT − 0.000871 × Neutrophil count − 0.000018 × Platelet count + 6.053793. The area under the curve was 98.55%. The sensitivity of the model to distinguish between disseminated histoplasmosis and tuberculosis was 95% (95% CI = 88.7–98.3%), and the specificity was 93% (95% CI = 85.7.3–97.4%). In conclusion, we here present a clinical-biological predictive score, using simple variables available on admission, that seemed to perform very well to discriminate disseminated histoplasmosis from tuberculosis in French Guiana in well characterized patients. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
16. [6th day dedicated to the scientific works of caregivers in French Guiana. Our caregivers have talent! May 25 & 26, 2023, Cayenne, French Guiana].
- Author
-
Deschamps C, Bardon T, Blaise T, Bonifay T, Boutrou M, Fremery A, Henry K, Lambert Y, LE Turnier P, Mutricy R, Oberlis M, Quintin B, Sauvage B, Thomas E, Epelboin L, and Hureau-Mutricy L
- Subjects
- Humans, French Guiana, Caregivers
- Published
- 2023
- Full Text
- View/download PDF
17. [Overview of infectious and non-infectious diseases in French Guiana in 2022].
- Author
-
Epelboin L, Abboud P, Abdelmoumen K, About F, Adenis A, Blaise T, Blaizot R, Bonifay T, Bourne-Watrin M, Boutrou M, Carles G, Carlier PY, Carod JF, Carvalho L, Couppié P, De Toffol B, Delon F, Demar M, Destoop J, Douine M, Droz JP, Elenga N, Enfissi A, Franck YK, Fremery A, Gaillet M, Kallel H, Kpangon AA, Lavergne A, Le Turnier P, Maisonobe L, Michaud C, Mutricy R, Nacher M, Naldjinan-Kodbaye R, Oberlis M, Odonne G, Osei L, Pujo J, Rabier S, Roman-Laverdure B, Rousseau C, Rousset D, Sabbah N, Sainte-Rose V, Schaub R, Sylla K, Tareau MA, Tertre V, Thorey C, Vialette V, Walter G, Zappa M, Djossou F, and Vignier N
- Subjects
- Animals, Humans, French Guiana epidemiology, Communicable Diseases, Cuniculidae, Histoplasmosis, HIV Infections, Noncommunicable Diseases, Q Fever, Toxoplasmosis diagnosis
- Abstract
Source of many myths, French Guiana represents an exceptional territory due to the richness of its biodiversity and the variety of its communities. The only European territory in Amazonia, surrounded by the Brazilian giant and the little-known Suriname, Ariane 6 rockets are launched from Kourou while 50% of the population lives below the poverty line. This paradoxical situation is a source of health problems specific to this territory, whether they be infectious diseases with unknown germs, intoxications or chronic pathologies.Some infectious diseases such as Q fever, toxoplasmosis, cryptococcosis or HIV infection are in common with temperate countries, but present specificities leading to sometimes different management and medical reasoning. In addition to these pathologies, many tropical diseases are present in an endemic and / or epidemic mode such as malaria, leishmaniasis, Chagas disease, histoplasmosis or dengue. Besides, Amazonian dermatology is extremely varied, ranging from rare but serious pathologies (Buruli ulcer, leprosy) to others which are frequent and benign such as agouti lice (mites of the family Trombiculidae) or papillonitis. Envenomations by wild fauna are not rare, and deserve an appropriate management of the incriminated taxon. Obstetrical, cardiovascular and metabolic cosmopolitan pathologies sometimes take on a particular dimension in French Guiana that must be taken into account in the management of patients. Finally, different types of intoxication are to be known by practitioners, especially due to heavy metals.European-level resources offer diagnostic and therapeutic possibilities that do not exist in the surrounding countries and regions, thus allowing the management of diseases that are not well known elsewhere.Thanks to these same European-level resources, research in Guyana occupies a key place within the Amazon region, despite a smaller population than in the surrounding countries. Thus, certain pathologies such as histoplasmosis of the immunocompromised patient, Amazonian toxoplasmosis or Q fever are hardly described in neighboring countries, probably due to under-diagnosis linked to more limited resources. French Guiana plays a leading role in the study of these diseases.The objective of this overview is to guide health care providers coming to or practicing in French Guiana in their daily practice, but also practitioners taking care of people returning from French Guiana., (Copyright © 2023 SFMTSI.)
- Published
- 2023
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.